5 hours Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts MarketBeat
Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have been assigned a consensus rating of “Buy” from the five analysts that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the s…
Nasdaq 100 · Pharmaceuticals · Science